Ubs Group Ag Haemonetics Corp Call Options Transaction History
Ubs Group Ag
- $397 Billion
- Q1 2024
Call Options
1 transactions
Others Institutions Holding HAE
# of Institutions
310Shares Held
50.1MCall Options Held
161KPut Options Held
56.3K-
Capital Research Global Investors Los Angeles, CA6.67MShares$567 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.98MShares$508 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$459 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.27MShares$363 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY3.79MShares$322 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.36B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...